CUE - Cue Biopharma, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2020)Next qtr. (Sep 2020)Current year (2020)Next year (2021)
No. of analysts5555
Avg. Estimate-0.43-0.43-1.74-1.74
Low estimate-0.48-0.5-2-2.41
High estimate-0.3-0.3-1.33-1.33
Year ago EPS-0.46-0.31-1.66-1.74
Revenue estimateCurrent qtr. (Jun 2020)Next qtr. (Sep 2020)Current year (2020)Next year (2021)
No. of analysts5555
Avg. Estimate2.09M2.09M7.69M12.81M
Low estimate810k730k3.09M1.12M
High estimate5.5M5.5M17.4M27.3M
Year ago salesN/A400k3.46M7.69M
Sales growth (year/est)N/A422.50%122.40%66.60%
Earnings history29/06/201929/09/201930/12/201930/03/2020
Est. EPS-0.56-0.44-0.45-0.35
Actual EPS-0.46-0.31-0.36-0.48
Difference0.10.130.09-0.13
Surprise %17.90%29.50%20.00%-37.10%
EPS trendCurrent qtr. (Jun 2020)Next qtr. (Sep 2020)Current year (2020)Next year (2021)
Current estimate-0.43-0.43-1.74-1.74
7 days ago-0.43-0.43-1.74-1.74
30 days ago-0.43-0.43-1.74-1.74
60 days ago-0.37-0.38-1.47-1.43
90 days ago-0.38-0.38-1.48-1.43
EPS revisionsCurrent qtr. (Jun 2020)Next qtr. (Sep 2020)Current year (2020)Next year (2021)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCUEIndustrySector(s)S&P 500
Current qtr.6.50%N/AN/AN/A
Next qtr.-38.70%N/AN/AN/A
Current year-4.80%N/AN/AN/A
Next yearN/AN/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A